Edwin Rock - Net Worth and Insider Trading
Edwin Rock Net Worth
The estimated net worth of Edwin Rock is at least $133,869 dollars as of 2024-05-06. Edwin Rock is the Chief Medical Officer of GlycoMimetics Inc and owns about 375,403 shares of GlycoMimetics Inc (GLYC) stock worth over $133,869. Details can be seen in Edwin Rock's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Edwin Rock has not made any transactions after 2023-09-22 and currently still holds the listed stock(s).
Transaction Summary of Edwin Rock
Edwin Rock Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Edwin Rock owns 1 companies in total, including GlycoMimetics Inc (GLYC) .
Click here to see the complete history of Edwin Rock’s form 4 insider trades.
Insider Ownership Summary of Edwin Rock
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
GLYC | GlycoMimetics Inc | 2023-09-22 | Chief Medical Officer |
Edwin Rock Latest Holdings Summary
Edwin Rock currently owns a total of 1 stock. Edwin Rock owns 375,403 shares of GlycoMimetics Inc (GLYC) as of September 22, 2023, with a value of $133,869.
Latest Holdings of Edwin Rock
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
GLYC | GlycoMimetics Inc | 2023-09-22 | 375,403 | 0.36 | 133,869 |
Holding Weightings of Edwin Rock
Edwin Rock Form 4 Trading Tracker
According to the SEC Form 4 filings, Edwin Rock has made a total of 3 transactions in GlycoMimetics Inc (GLYC) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in GlycoMimetics Inc is the acquisition of 65,403 shares on September 22, 2023, which cost Edwin Rock around $90,256.
Insider Trading History of Edwin Rock
- 1
Edwin Rock Trading Performance
GuruFocus tracks the stock performance after each of Edwin Rock's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Edwin Rock is 10.2%. GuruFocus also compares Edwin Rock's trading performance to market benchmark return within the same time period. The performance of stocks bought by Edwin Rock within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Edwin Rock's insider trading performs compared to the benchmark.
Edwin Rock Ownership Network
Ownership Network List of Edwin Rock
Ownership Network Relation of Edwin Rock
Edwin Rock Owned Company Details
What does GlycoMimetics Inc do?
Who are the key executives at GlycoMimetics Inc?
Edwin Rock is the Chief Medical Officer of GlycoMimetics Inc. Other key executives at GlycoMimetics Inc include CFO Brian M. Hahn , SVP & Chief Commercial Officer Bruce S Johnson , and SVP and Chief Business Officer Chinmaya Rath .
GlycoMimetics Inc (GLYC) Insider Trades Summary
Over the past 18 months, Edwin Rock made 3 insider transaction in GlycoMimetics Inc (GLYC) with a net purchase of 375,403. Other recent insider transactions involving GlycoMimetics Inc (GLYC) include a net purchase of 2,026,717 shares made by Invus Public Equities, L.p. , a net sale of 4,121,511 shares made by Scott D Sandell , and a net purchase of 50,000 shares made by Daniel M Junius .
In summary, during the past 3 months, insiders sold 0 shares of GlycoMimetics Inc (GLYC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 4,125,211 shares of GlycoMimetics Inc (GLYC) were sold and 2,581,565 shares were bought by its insiders, resulting in a net sale of 1,543,646 shares.
GlycoMimetics Inc (GLYC)'s detailed insider trading history can be found in Insider Trading Tracker table.
GlycoMimetics Inc Insider Transactions
Edwin Rock Mailing Address
Above is the net worth, insider trading, and ownership report for Edwin Rock. You might contact Edwin Rock via mailing address: 9708 Medical Center Drive, Rockville Md 20850.